Postoperative use of the chemopreventive vitamin K2 analog in patients with hepatocellular carcinoma.
<h4>Aim</h4>To evaluate the chemopreventive efficacy of vitamin K2 (VK2) analog in patients with hepatocellular carcinoma (HCC) after curative hepatic resection or local ablation, since a recent randomized control trial (RCT) and systematic review have given contradictory results.<h4&...
Saved in:
Main Authors: | Jian-Hong Zhong, Xin-Shao Mo, Bang-De Xiang, Wei-Ping Yuan, Jin-Fang Jiang, Gui-Sheng Xie, Le-Qun Li |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/d68bf9e1c45f430bac18b6bbf9b63b4b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.
by: Jian-Hong Zhong, et al.
Published: (2013) -
Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
by: Yang Yang, et al.
Published: (2021) -
Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.
by: Jian-Hong Zhong, et al.
Published: (2013) -
Vitamin K2 Inhibits Hepatocellular Carcinoma Cell Proliferation by Binding to 17β-Hydroxysteroid Dehydrogenase 4
by: Xin Lu, et al.
Published: (2021) -
Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma.
by: Ya-Hui Huang, et al.
Published: (2012)